MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
Consolidators: BioPharmaceuticals
Consolidators: Bio-Pharmaceuticals_Generics
Allergan, AGN (NYSE), formerly, Actavis Inc (ACT)
Organization & Developments: Allergan
Parents
2008: MHS-Military Health System (Annual Conference 2008)
Allergan Inc. (AGN) #15 Medical Device (2013)
Allergan, AGN (NYSE), formerly, Actavis Inc (ACT)
Children
2011: Multi-specialty health care company established 60 years ago (2011)
2012: Allergan, Molecular Partners team on drug development (2012)
2015: Actavis plc is now Allergan plc
2015: Allergan bets $125M on a new approach to dry eye disease
2016: Allergan: Life After Pfizer - Allergan plc (NYSE:AGN)
2016: Allergan: Low Enough To Like, Or Valeant-Lite? - Allergan plc (NYSE:AGN)
2016: Is Allergan Just A High-Class Valeant? - Allergan plc (NYSE:AGN)
2017: Adamas Pharmaceuticals: Still Upside After Big Rally - Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)
2017: Potential Breakthrough Option For Parkinson's: LTI Partners With Allergan
2018: T2 Biosystems - A Busted IPO For 2018 - Bret Jensen
2018: VA_65--Allergan USA, Inc. Contract Award Effective 9/30/2018
2019: 8 programs to watch in NASH: Four letters and a multibillion-dollar opportunity
2019: Allergan In NASH, And The Market Assessment_seekingalpha.com
2019: Allergan’s $560M buyout deal just led to a PhIII debacle as another depression drug goes down to bitter defeat – Endpoints News
2525 Dupont Drive
Allergan Pharmaceuticals Ireland Ltd
Organization & Developments: Actavis
Jumps
*Key People: Allergan
Finance & Acquisitions: Allergan